These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 55924)

  • 41. Factors in the pathogenesis of experimental nonketotic and ketoacidotic diabetic stupor.
    Joffe BI; Seftel HC; Goldberg R; Van As M; Krut L; Bersohn I
    Diabetes; 1973 Sep; 22(9):653-7. PubMed ID: 4199491
    [No Abstract]   [Full Text] [Related]  

  • 42. [Blood level of ketone bodies and its clinical significance].
    Harano Y
    Nihon Rinsho; 2002 Aug; 60 Suppl 8():420-32. PubMed ID: 12355785
    [No Abstract]   [Full Text] [Related]  

  • 43. Euglycaemic diabetic ketoacidosis in pregnancy: an unusual presentation.
    Oliver R; Jagadeesan P; Howard RJ; Nikookam K
    J Obstet Gynaecol; 2007 Apr; 27(3):308. PubMed ID: 17464819
    [No Abstract]   [Full Text] [Related]  

  • 44. Insulin deficiency and hyperosmolar coma.
    Foster DW
    Adv Intern Med; 1974; 19():159-73. PubMed ID: 4205604
    [No Abstract]   [Full Text] [Related]  

  • 45. [Treatment of diabetic ketoacidosis in children].
    Vanelli M; Bernasconi S; Rossi S; Rocca M; Turni A; Giovannelli G
    Arch Fr Pediatr; 1982 Apr; 39(4):203-7. PubMed ID: 6812531
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [New concepts in the treatment of diabetic ketoacidosis].
    Kaloianov K
    Vutr Boles; 1984; 23(4):6-9. PubMed ID: 6095536
    [No Abstract]   [Full Text] [Related]  

  • 47. [Importance of the determination of plasmatic free fatty acids (F.F.A.) in diabetic children].
    Ceterchi D; Opincaru A
    Pediatria (Bucur); 1967; 16(2):153-8. PubMed ID: 4963129
    [No Abstract]   [Full Text] [Related]  

  • 48. Blood ketone bodies in patients with recent-onset type 1 diabetes (a multicenter study).
    Prisco F; Picardi A; Iafusco D; Lorini R; Minicucci L; Martinucci ME; Toni S; Cerutti F; Rabbone I; Buzzetti R; Crino A; Pozzilli P
    Pediatr Diabetes; 2006 Aug; 7(4):223-8. PubMed ID: 16911010
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hydroxybutyrate near-patient testing to evaluate a new end-point for intravenous insulin therapy in the treatment of diabetic ketoacidosis in children.
    Noyes KJ; Crofton P; Bath LE; Holmes A; Stark L; Oxley CD; Kelnar CJ
    Pediatr Diabetes; 2007 Jun; 8(3):150-6. PubMed ID: 17550425
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rapid blood ketone body estimation in the diagnosis of diabetic ketoacidosis.
    Alberti KG; Hockaday TD
    Br Med J; 1972 Jun; 2(5813):565-8. PubMed ID: 4624389
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Treatment of severe diabetic ketoacidosis in children. A comparative study of two methods (author's transl)].
    Dieterlen P; Charlochet F; Desjeux JF; Lestradet H
    Ann Pediatr (Paris); 1981 Sep; 28(7):499-503. PubMed ID: 6792973
    [No Abstract]   [Full Text] [Related]  

  • 52. Effect of normal saline and half normal saline on serum electrolytes during recovery phase of diabetic ketoacidosis.
    Basnet S; Venepalli PK; Andoh J; Verhulst S; Koirala J
    J Intensive Care Med; 2014; 29(1):38-42. PubMed ID: 23753222
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Persistence of ketosis despite suppression of lipolysis by 16,16-dimethylprostaglandin E2 in experimental diabetic ketoacidosis in rats.
    Axelrod L; Slowman SD; Lloyd-Jones P; Martin DB
    Diabetes; 1979 Oct; 28(10):905-13. PubMed ID: 113273
    [No Abstract]   [Full Text] [Related]  

  • 54. Treatment of diabetic ketoacidosis by direct addition of insulin to intravenous infusion. A comparison of "high dose" and "low dose" techniques.
    Harrower AD
    Br J Clin Pract; 1979 Mar; 33(3):85-6. PubMed ID: 109109
    [No Abstract]   [Full Text] [Related]  

  • 55. [Metabolic risks of salbutamol in diabetic patients. A study using somatostatin (author's transl)].
    Schlienger JL; Compagnie MJ; Dellenbach P; Stephan F
    Nouv Presse Med; 1980 Sep; 9(32):2247-51. PubMed ID: 6106923
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy of combined insulin and somatostatin infusion for the treatment of experimental diabetic ketoacidosis.
    Harano Y; Ohgaku S; Hidaka H; Takatsuki K; Shigeta Y
    Horm Metab Res; 1979 May; 11(5):338-42. PubMed ID: 113327
    [No Abstract]   [Full Text] [Related]  

  • 57. Can serum beta-hydroxybutyrate be used to diagnose diabetic ketoacidosis?
    Sheikh-Ali M; Karon BS; Basu A; Kudva YC; Muller LA; Xu J; Schwenk WF; Miles JM
    Diabetes Care; 2008 Apr; 31(4):643-7. PubMed ID: 18184896
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Letter: Insulin in the management of diabetic ketoacidosis.
    Ghirlanda G; Rebuzzi AG; Altomonte L; Manna R; Di Mauro P; Greco AV
    Lancet; 1976 Feb; 1(7956):419. PubMed ID: 55669
    [No Abstract]   [Full Text] [Related]  

  • 59. Letter: Treatment of diabetic ketoacidosis.
    N Engl J Med; 1976 May; 294(21):1183-4. PubMed ID: 817199
    [No Abstract]   [Full Text] [Related]  

  • 60. Somatostatin and water excretion.
    René E; Gardin JP; Trinchet JC; Chayvialle J; Paillard M; Bonfils S
    Lancet; 1983 Sep; 2(8351):689. PubMed ID: 6136834
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.